John Wickersham

1.0k total citations
10 papers, 724 citations indexed

About

John Wickersham is a scholar working on Molecular Biology, Infectious Diseases and Anthropology. According to data from OpenAlex, John Wickersham has authored 10 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Anthropology. Recurrent topics in John Wickersham's work include Angiogenesis and VEGF in Cancer (2 papers), Biochemical and Molecular Research (2 papers) and Hepatitis C virus research (2 papers). John Wickersham is often cited by papers focused on Angiogenesis and VEGF in Cancer (2 papers), Biochemical and Molecular Research (2 papers) and Hepatitis C virus research (2 papers). John Wickersham collaborates with scholars based in United States and Japan. John Wickersham's co-authors include Zuzana Hostomska, Zdeněk Hostomský, Hans E. Parge, Robert A. Love, Noriyuki Habuka, Ellen W. Moomaw, Tsuyoshi Adachi, Chao‐Zhou Ni, R. Kodandapani and Kathryn R. Ely and has published in prestigious journals such as Cell, Cancer Research and The American Historical Review.

In The Last Decade

John Wickersham

10 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Wickersham United States 8 340 314 216 140 126 10 724
Joachim Jaeger United States 15 254 0.7× 472 1.5× 231 1.1× 60 0.4× 124 1.0× 21 830
Muriel Lavie France 16 307 0.9× 202 0.6× 285 1.3× 123 0.9× 92 0.7× 23 769
Richard Ingram United States 12 154 0.5× 187 0.6× 138 0.6× 109 0.8× 182 1.4× 14 566
S. Shane Taremi United States 11 359 1.1× 250 0.8× 217 1.0× 111 0.8× 159 1.3× 14 712
John R. Fulghum United States 10 394 1.2× 382 1.2× 340 1.6× 108 0.8× 215 1.7× 15 797
Linda Bartholomew Italy 11 668 2.0× 237 0.8× 505 2.3× 102 0.7× 364 2.9× 14 962
Mireille Cartier Canada 13 168 0.5× 485 1.5× 229 1.1× 33 0.2× 114 0.9× 17 826
Julie Q. Hang United States 16 238 0.7× 257 0.8× 228 1.1× 39 0.3× 340 2.7× 20 718
Marie-Josée Massariol Canada 12 119 0.3× 179 0.6× 340 1.6× 41 0.3× 161 1.3× 15 542
Takuya Umehara Japan 15 167 0.5× 951 3.0× 157 0.7× 51 0.4× 53 0.4× 32 1.1k

Countries citing papers authored by John Wickersham

Since Specialization
Citations

This map shows the geographic impact of John Wickersham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Wickersham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Wickersham more than expected).

Fields of papers citing papers by John Wickersham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Wickersham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Wickersham. The network helps show where John Wickersham may publish in the future.

Co-authorship network of co-authors of John Wickersham

This figure shows the co-authorship network connecting the top 25 collaborators of John Wickersham. A scholar is included among the top collaborators of John Wickersham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Wickersham. John Wickersham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Marrone, Tami, Dana D. Hu‐Lowe, Maren L. Grazzini, et al.. (2007). PF-00337210, a potent, selective and orally bioavailable small molecule inhibitor of VEGFR-2. Cancer Research. 67. 3992–3992. 7 indexed citations
2.
McTigue, Michele, John Wickersham, Richard E. Showalter, et al.. (1999). Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis. Structure. 7(3). 319–330. 161 indexed citations
3.
Love, Robert A., Hans E. Parge, John Wickersham, et al.. (1998). The conformation of hepatitis C virus NS3 proteinase with and without NS4A: a structural basis for the activation of the enzyme by its cofactor. Clinical and Diagnostic Virology. 10(2-3). 151–156. 34 indexed citations
4.
Love, Robert A., Hans E. Parge, John Wickersham, et al.. (1996). The Crystal Structure of Hepatitis C Virus NS3 Proteinase Reveals a Trypsin-like Fold and a Structural Zinc Binding Site. Cell. 87(2). 331–342. 398 indexed citations
5.
Ni, Chao‐Zhou, Richard S. Mitchell, John Wickersham, et al.. (1996). Crystal structure of the coat protein from the GA bacteriophage: Model of the unassembled dimer. Protein Science. 5(12). 2485–2493. 15 indexed citations
6.
Verbrugghe, Gerald P. & John Wickersham. (1996). Berossos and Manetho, Introduced and Translated. University of Michigan Press eBooks. 18 indexed citations
7.
Ni, Chao‐Zhou, et al.. (1995). Crystal structure of the MS2 coat protein dimer: implications for RNA binding and virus assembly. Structure. 3(3). 255–263. 81 indexed citations
8.
Wickersham, John, et al.. (1995). Athens on Trial: The Antidemocratic Tradition in Western Thought.. The American Historical Review. 100(5). 1522–1522. 7 indexed citations
9.
Wickersham, John & Robert Garland. (1994). Introducing New Gods: The Politics of Athenian Religion.. The American Historical Review. 99(4). 1293–1293. 1 indexed citations
10.
Burford, Alison, John Wickersham, & Gerald P. Verbrugghe. (1976). Greek Historical Documents. The Fourth Century B. C.. The Classical World. 70(1). 36–36. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026